OR WAIT null SECS
Health Level Seven International (HL7), a not-for-profit, ANSI-accredited standards developing organization for interoperability in healthcare information technology, announced the appointment of
Wayne R. Kubick as the organization’s new Chief Technology Officer (CTO). In this position, Kubick will have responsibilities for advancing HL7’s mission and strategic plan. He will help to lead HL7 work groups to develop and maintain HL7’s product lines and serve as a technical advisor, liaison and spokesperson for the organization. The CTO also oversees the HL7 Terminology Authority, is the vice chair of the Technical Steering Committee (TSC) and an active member of the Architectural Review Board (ARB). Kubick is also a member of Applied Clinical Trials Editorial Advisory Board.
CRO Emmes Corporation announced that Paul VanVeldhuisen, PhD,
has been promoted to the newly created position of chief operating officer. VanVeldhuisen, who started at Emmes as a statistician and epidemiologist, will assume the additional leadership responsibilities while continuing to serve as principal investigator for government and privately funded research projects.
Certara, a global biosimulation technology-enabled drug development company, has appointed Andrzej Kierzek, PhD, as head of systems modeling in its Simcyp® Quantitative Systems Pharmacology (QSP) Group. He joins Certara from the University of Surrey, UK, where he serves as professor of systems biology.
CRF Health, a global provider of eCOA solutions for the life sciences industry, has appointed Peter van Tiggelen as the company's Chief Financial Officer (CFO). CRF Health also named Claudine Paccio as the company's Senior Vice President, Delivery Services. Prior to joining CRF Health, she was Vice President of Operations for Bioclinica's eClinical division.
CRO ClinTec International has appointed Robert Reekie as Chief Operating Officer (COO) (below left) & Senior Executive Vice President, and Harley Simon, as Chief Medical Officer (CMO) and Executive Vice President (EVP) Client Relations.
CTI Clinical Trial and Consulting Services has made the following new hires, Jacqueline Bond, Research Associate; Brittany Donovan, Senior Study Coordinator (below, left) ; Flávia Gois as Clinical Trial Assistant, Latin America; Jennifer Graham, Senior Administrative Assistant, Accounting (below, right); Ryan Imhoff, Research Associate; Melissa Martz as Senior Clinical Safety Scientist and Gregory Spicer joins as IT Support Specialist.
In addition, CTI has promoted the following employees: Rick Bohnke promoted to Assistant Director, Clinical Data Management; Lisa Campbell to Assistant Study Manager; Brian Lawrence to Senior Manager, Taxation and Financial Planning/Analysis; Dave McCollum to Director, Biostatistics; Robert McRae to Manager, Business Development & Client Management; and Jaynee Tolle to Senior Financial Analyst.
(pictured upper left to lower right: Bohnke, McCollumn, McRae and Tolle).
TrialScope, a provider of clinical trial transparency and compliance solutions, announced that Chris Campbell has joined its leadership team as Chief Customer Officer.
Crown Bioscience, a global drug discovery and development services company has appointed Eric Murphy, PhD, as global scientific director for translational oncology. Most recently, Murphy designed and implemented a world-class screening operation for a biotechnology company focused on regenerative medicine. This led to phenotypic screening and compound profiling to support both discovery and translational research programs.
Radiant Sage, a clinical trial imaging provider, announced that Robert Ford, MD, has been named as its Chief Medical Advisor. In this adjunct role Ford will help Radiant Sage deliver high quality medical services to its clients. In 1998, Dr. Ford founded RadPharm, an imaging core lab and was president and Chief Medical Officer (CMO) until 2008.
US Oncology Research, a large community-based oncology research organization, has recruited its 2,000th patient to participate in a Phase I clinical trial through its Translational Oncology Program (TOP). The TOP Program provides guidance, resources and support so physicians in community-based cancer centers can offer Phase I trials to their patients.
Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, will introduce clinical supply services at its 200,000 sq. ft. cGMP facility in Kakegawa, Japan. The site will provide full-service solutions, including project management and clinical supply management, comparator sourcing, secondary packaging and labeling, clinical storage, distribution, and drug return and destruction.
ERT, a cloud platform solutions provider, announced that for the third consecutive year, over 50% of the compounds approved by U.S. FDA have utilized its cardiac safety, respiratory, and/or electronic Clinical Outcome Assessment (eCOA) solutions to capture critical safety and/or efficacy data during clinical development.
Quintiles was awarded the HR.com 2016 Leadership Excellence Award for Innovation in Deployment of Leadership Programs, for the global deployment of its Leadership Key Talent Initiative. HR.com is committed to providing a deeper understanding of the HR function for over 250,000 members.